GlassScriptPhysician profile
Wesley C Mills
NPI 1902847445
$3,286.36
in general payments reported to CMS, 2019-2025
16 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what 90% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,528 · 2020: $177 · 2021: $147 · 2022: $134 · 2023: $149 · 2024: $36.82 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $908 · Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $907.95 |
| Food and Beverage | $391.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $907.95 | 2025 | |
| Pfizer INC. | $679.92 | 2019-2025 | |
| Novo Nordisk INC | $320.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $268.63 | 2019-2020 | |
| Abbott Laboratories | $146.77 | 2021 | |
| Tepha INC | $141.71 | 2019 | |
| Medtronic, INC. | $134.49 | 2022 | |
| Viiv Healthcare Company | $125.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Lilly USA, LLC | $122.43 | 2019 | |
| Abbvie INC. | $119.75 | 2019 | |
| Idorsia Pharmaceuticals US INC | $84.20 | 2023 | Quviviq |
| Medtronic USA, INC. | $49.02 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $20.62 | 2019 | |
| Amarin Pharma, INC. | $20.21 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.